{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:49:36Z","timestamp":1794005376735,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["No. QKHJC-ZK[2022]ZD031"],"award-info":[{"award-number":["No. QKHJC-ZK[2022]ZD031"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03256-z","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:14:05Z","timestamp":1770473645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A trifluoromethyl quinoline derivative targets SGK1 and modulates the PI3K\/AKT pathway to inhibit prostate cancer progression"],"prefix":"10.1007","volume":"43","author":[{"given":"Xianhui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingsheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"issue":"3","key":"3256_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"3256_CR2","doi-asserted-by":"publisher","unstructured":"Wasim S, Lee SY, Kim J. Complexities of prostate cancer. Int J Mol Sci. 2022;23(22). https:\/\/doi.org\/10.3390\/ijms232214257.","DOI":"10.3390\/ijms232214257"},{"key":"3256_CR3","doi-asserted-by":"publisher","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A, Cancer statistics. 2025. CA Cancer J Clin. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","DOI":"10.3322\/caac.21871"},{"issue":"26","key":"3256_CR4","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1200\/jco.23.00433","volume":"41","author":"C Dai","year":"2023","unstructured":"Dai C, Dehm SM, Sharifi N. Targeting the androgen signaling axis in prostate cancer. J Clin Oncol. 2023;41(26):4267\u201378. https:\/\/doi.org\/10.1200\/jco.23.00433.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3256_CR5","doi-asserted-by":"publisher","first-page":"188625","DOI":"10.1016\/j.bbcan.2021.188625","volume":"1876","author":"MY Konoshenko","year":"2021","unstructured":"Konoshenko MY, Bryzgunova OE, Laktionov PP. MiRNAs and androgen deprivation therapy for prostate cancer. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188625. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188625.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"3256_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai K, McManus JM, Sharifi N. Hormonal therapy for prostate cancer. Endocr Rev. 2021;42(3):354\u201373. https:\/\/doi.org\/10.1210\/endrev\/bnab002.","journal-title":"Endocr Rev"},{"key":"3256_CR7","doi-asserted-by":"publisher","unstructured":"Zhang H, Zhou Y, Xing Z, Sah RK, Hu J, Hu H. Androgen metabolism and response in prostate cancer Anti-Androgen therapy resistance. Int J Mol Sci. 2022;23(21). https:\/\/doi.org\/10.3390\/ijms232113521.","DOI":"10.3390\/ijms232113521"},{"key":"3256_CR8","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68:100962. https:\/\/doi.org\/10.1016\/j.drup.2023.100962.","journal-title":"Drug Resist Updat"},{"key":"3256_CR9","doi-asserted-by":"publisher","first-page":"1036844","DOI":"10.3389\/fphar.2022.1036844","volume":"13","author":"H Jang","year":"2022","unstructured":"Jang H, Park Y, Jang J. Serum and glucocorticoid-regulated kinase 1: Structure, biological functions, and its inhibitors. Front Pharmacol. 2022;13:1036844. https:\/\/doi.org\/10.3389\/fphar.2022.1036844.","journal-title":"Front Pharmacol"},{"key":"3256_CR10","doi-asserted-by":"publisher","first-page":"175883592094094","DOI":"10.1177\/1758835920940946","volume":"12","author":"R Zhu","year":"2020","unstructured":"Zhu R, Yang G, Cao Z, Shen K, Zheng L, Xiao J, et al. The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star. Ther Adv Med Oncol. 2020;12:1758835920940946. https:\/\/doi.org\/10.1177\/1758835920940946.","journal-title":"Ther Adv Med Oncol"},{"key":"3256_CR11","doi-asserted-by":"publisher","first-page":"608722","DOI":"10.3389\/fonc.2020.608722","volume":"10","author":"Y Sang","year":"2020","unstructured":"Sang Y, Kong P, Zhang S, Zhang L, Cao Y, Duan X, et al. SGK1 in human cancer: emerging roles and mechanisms. Front Oncol. 2020;10:608722. https:\/\/doi.org\/10.3389\/fonc.2020.608722.","journal-title":"Front Oncol"},{"key":"3256_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ejmech.2014.07.044","volume":"97","author":"O Afzal","year":"2015","unstructured":"Afzal O, Kumar S, Haider MR, Ali MR, Kumar R, Jaggi M, et al. A review on anticancer potential of bioactive heterocycle Quinoline. Eur J Med Chem. 2015;97:871\u2013910. https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.044.","journal-title":"Eur J Med Chem"},{"key":"3256_CR13","doi-asserted-by":"publisher","first-page":"115973","DOI":"10.1016\/j.bmc.2020.115973","volume":"32","author":"BS Matada","year":"2021","unstructured":"Matada BS, Pattanashettar R, Yernale NG. A comprehensive review on the biological interest of Quinoline and its derivatives. Bioorg Med Chem. 2021;32:115973. https:\/\/doi.org\/10.1016\/j.bmc.2020.115973.","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"3256_CR14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1021\/acs.jmedchem.1c00963","volume":"65","author":"CC Ayala-Aguilera","year":"2022","unstructured":"Ayala-Aguilera CC, Valero T, Lorente-Mac\u00edas \u00c1, Baillache DJ, Croke S, Unciti-Broceta A. Small molecule kinase inhibitor drugs (1995\u20132021): medical Indication, Pharmacology, and synthesis. J Med Chem. 2022;65(2):1047\u2013131. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00963.","journal-title":"J Med Chem"},{"issue":"4","key":"3256_CR15","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1021\/cr4002879","volume":"114","author":"J Wang","year":"2014","unstructured":"Wang J, S\u00e1nchez-Rosell\u00f3 M, Ace\u00f1a JL, del Pozo C, Sorochinsky AE, Fustero S, et al. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001\u20132011). Chem Rev. 2014;114(4):2432\u2013506. https:\/\/doi.org\/10.1021\/cr4002879.","journal-title":"Chem Rev"},{"issue":"3","key":"3256_CR16","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s11030-024-10951-4","volume":"29","author":"G Xu","year":"2025","unstructured":"Xu G, Li L, Lv M, Li C, Yu J, Zeng X, et al. Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1. Mol Divers. 2025;29(3):1945\u201365. https:\/\/doi.org\/10.1007\/s11030-024-10951-4.","journal-title":"Mol Divers"},{"key":"3256_CR17","doi-asserted-by":"publisher","first-page":"117336","DOI":"10.1016\/j.ejmech.2025.117336","volume":"287","author":"C Li","year":"2025","unstructured":"Li C, Cheng S, Yu J, Zheng Q, Yu G, Xu M, et al. Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity. Eur J Med Chem. 2025;287:117336. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117336.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"3256_CR18","doi-asserted-by":"publisher","first-page":"17599","DOI":"10.1038\/s41598-022-22294-x","volume":"12","author":"SC Taylor","year":"2022","unstructured":"Taylor SC, Rosselli-Murai LK, Crobeddu B, Plante I. A critical path to producing high quality, reproducible data from quantitative Western blot experiments. Sci Rep. 2022;12(1):17599. https:\/\/doi.org\/10.1038\/s41598-022-22294-x.","journal-title":"Sci Rep"},{"issue":"9\u201310","key":"3256_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14789450.2024.2406785","volume":"21","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang Y, Zheng C, Zhou Z, Chen Z. Cellular thermal shift assay: an approach to identify and assess protein target engagement. Expert Rev Proteom. 2024;21(9\u201310):387\u2013400. https:\/\/doi.org\/10.1080\/14789450.2024.2406785.","journal-title":"Expert Rev Proteom"},{"issue":"17","key":"3256_CR20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMe2300807","volume":"388","author":"O Sartor","year":"2023","unstructured":"Sartor O. Localized prostate Cancer - Then and now. N Engl J Med. 2023;388(17):1617\u20138. https:\/\/doi.org\/10.1056\/NEJMe2300807.","journal-title":"N Engl J Med"},{"issue":"11","key":"3256_CR21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s11912-024-01614-6","volume":"26","author":"MNE Almeeri","year":"2024","unstructured":"Almeeri MNE, Awies M, Constantinou C. Prostate Cancer, pathophysiology and recent developments in management: A narrative review. Curr Oncol Rep. 2024;26(11):1511\u20139. https:\/\/doi.org\/10.1007\/s11912-024-01614-6.","journal-title":"Curr Oncol Rep"},{"key":"3256_CR22","doi-asserted-by":"publisher","unstructured":"Mallah H, Diabasana Z, Soultani S, Idoux-Gillet Y, Massfelder T. Prostate cancer: A journey through its history and recent developments. Cancers (Basel). 2025;17(2). https:\/\/doi.org\/10.3390\/cancers17020194.","DOI":"10.3390\/cancers17020194"},{"key":"3256_CR23","doi-asserted-by":"publisher","first-page":"107932","DOI":"10.1016\/j.pharmthera.2021.107932","volume":"228","author":"M Adamaki","year":"2021","unstructured":"Adamaki M, Zoumpourlis V. Prostate cancer biomarkers: from diagnosis to prognosis and precision-guided therapeutics. Pharmacol Ther. 2021;228:107932. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107932.","journal-title":"Pharmacol Ther"},{"issue":"10","key":"3256_CR24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate Cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(10):1067\u201396. https:\/\/doi.org\/10.6004\/jnccn.2023.0050.","journal-title":"J Natl Compr Canc Netw"},{"key":"3256_CR25","doi-asserted-by":"publisher","first-page":"217155","DOI":"10.1016\/j.canlet.2024.217155","volume":"601","author":"D Liu","year":"2024","unstructured":"Liu D, Wang L, Guo Y. Advances in and prospects of immunotherapy for prostate cancer. Cancer Lett. 2024;601:217155. https:\/\/doi.org\/10.1016\/j.canlet.2024.217155.","journal-title":"Cancer Lett"},{"key":"3256_CR26","doi-asserted-by":"publisher","unstructured":"Xiong YF, Li C, Yu J, Chen X, Cheng S, Liu XY, et al. A novel trifluoromethyl Quinoline derivative targeting SGK1 inducing autophagy and apoptosis via regulating mTOR\/FOXO3a pathway in glioblastoma. Arab J Chem. 2024;17(9). https:\/\/doi.org\/10.1016\/j.arabjc.2024.105909.","DOI":"10.1016\/j.arabjc.2024.105909"},{"key":"3256_CR27","doi-asserted-by":"publisher","first-page":"822303","DOI":"10.3389\/fimmu.2022.822303","volume":"13","author":"RQ Lu","year":"2022","unstructured":"Lu RQ, Zhang YY, Zhao HQ, Guo RQ, Jiang ZX, Guo R. SGK1, a critical regulator of immune modulation and fibrosis and a potential therapeutic target in chronic Graft-Versus-Host disease. Front Immunol. 2022;13:822303. https:\/\/doi.org\/10.3389\/fimmu.2022.822303.","journal-title":"Front Immunol"},{"key":"3256_CR28","doi-asserted-by":"publisher","unstructured":"Al-Alem U, Rauscher GH, Alem QA, Kajdacsy-Balla A, Mahmoud AM. Prognostic value of SGK1 and Bcl-2 in invasive breast cancer. Cancers (Basel). 2023;15(12). https:\/\/doi.org\/10.3390\/cancers15123151.","DOI":"10.3390\/cancers15123151"},{"issue":"1","key":"3256_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","volume":"7","author":"Y He","year":"2022","unstructured":"29, He Y, Xu W, Xiao YT, Huang H, Gu D, Ren S. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials. Signal Transduct Target Ther. 2022;7(1):198. https:\/\/doi.org\/10.1038\/s41392-022-01042-7.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03256-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03256-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:03:47Z","timestamp":1775649827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-026-03256-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["3256"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03256-z","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"146"}}